ArticleCureus2026
Guillain-Barré Syndrome As the Initial Manifestation of Human Immunodeficiency Virus Infection: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy typically triggered by an antecedent infection. Human immunodeficiency virus (HIV) is an uncommon but recognized association, and GBS may rarely constitute the first clinical manifestation of previously undiagnosed HIV infection. A 36-year-old man presented with subacute facial diplegia, predominantly distal tetraparesis, sensory ataxia, glove-and-stocking paresthesia, and hyporeflexia. Cerebrospinal fluid (CSF) analysis showed albuminocytologic dissociation; electrophysiological studies demonstrated a sensorimotor polyradiculoneuropathy with prominent demyelinating features, supporting the diagnosis of GBS. He received a five-day course of intravenous immunoglobulin (IVIG) with initial modest improvement followed by subsequent marked neurological deterioration and respiratory failure requiring invasive mechanical ventilation and a second IVIG course. Etiological investigation revealed previously undiagnosed HIV-1 infection and concomitant syphilis. Antiretroviral therapy was initiated, and presumptive neurosyphilis was treated with ceftriaxone. The patient developed autonomic instability and required tracheostomy for prolonged ventilatory weaning. He was transferred after an 89-day hospital stay with residual tetraparesis, predominantly affecting the lower limbs. GBS may be the initial presentation leading to the diagnosis of previously unrecognized HIV infection. Concomitant syphilis added diagnostic complexity, requiring integration of clinical, electrophysiological, CSF, microbiological, and serological findings and cautious causal interpretation. This case supports considering HIV testing in otherwise unexplained acute inflammatory polyradiculoneuropathy and highlights the potential severity of HIV-associated GBS, including autonomic and respiratory complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.